|
|
|
Insider
Information: |
Skovronsky Daniel |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
203,913 |
|
Indirect Shares
|
75,616 |
|
|
Direct
Value |
$109,467,598 |
|
|
Indirect Value
|
$68,759,141 |
|
|
Total
Shares |
279,529 |
|
|
Total
Value |
$178,226,739 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
EVP, CSO & Pres. LRL &... |
2024-09-11 |
117,903 |
2024-09-11 |
75,616 |
Premium* |
|
Myriad Genetics Inc |
MYGN |
Director |
2024-06-06 |
86,010 |
2020-07-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
SVP, CSO, and Pres. LRL |
|
2018-06-14 |
4 |
B |
$86.22 |
$862,200 |
D/D |
10,000 |
55,199 |
2.74 |
- |
|
LLY |
Eli Lilly & Co |
SVP, CSO, and Pres. LRL |
|
2019-02-04 |
4 |
A |
$120.17 |
$1,876,935 |
D/D |
15,619 |
70,818 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP, CSO, and Pres. LRL |
|
2019-10-25 |
4 |
B |
$108.61 |
$543,050 |
D/D |
5,000 |
75,818 |
2.74 |
- |
|
LLY |
Eli Lilly & Co |
SVP, CSO, and Pres. LRL |
|
2020-02-11 |
4 |
A |
$144.25 |
$3,078,439 |
D/D |
21,341 |
97,159 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
25,041 |
25,041 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2020-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
15,889 |
40,930 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP, CSO, and Pres. LRL |
|
2021-02-08 |
4 |
A |
$205.77 |
$3,811,066 |
D/D |
18,521 |
115,680 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,848 |
37,889 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP, CS&MO & Pres. LRL |
|
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,735 |
64,415 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP, CS&MO & Pres. LRL |
|
2022-02-01 |
4 |
D |
$245.39 |
$2,070,355 |
D/D |
(8,437) |
55,978 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP, CS&MO & Pres. LRL |
|
2022-02-09 |
4 |
A |
$243.27 |
$5,493,280 |
D/D |
22,581 |
78,559 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,275 |
55,164 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CS&MO & Pres., LRL |
|
2023-02-01 |
4 |
D |
$344.15 |
$2,421,095 |
D/D |
(7,035) |
87,199 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CS&MO & Pres., LRL |
|
2023-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,675 |
94,234 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CS&MO & Pres., LRL |
|
2023-02-10 |
4 |
A |
$345.12 |
$6,346,067 |
D/D |
18,388 |
105,587 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,151 |
70,315 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CS&MO & Pres., LRL |
|
2023-08-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
249 |
105,338 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CS&MO & Pres., LRL |
|
2023-11-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
17 |
105,321 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CSO & Pres. LRL & LLY Imm |
|
2024-02-01 |
4 |
D |
$645.61 |
$2,862,635 |
D/D |
(4,434) |
110,828 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CSO & Pres. LRL & LLY Imm |
|
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,941 |
115,262 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CSO & Pres. LRL & LLY Imm |
|
2024-02-12 |
4 |
A |
$737.26 |
$9,518,027 |
D/D |
12,910 |
123,738 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,695 |
86,010 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CSO & Pres. LRL & LLY Imm |
|
2024-09-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
111 |
123,627 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, CSO & Pres. LRL & LLY Imm |
|
2024-09-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,724 |
117,903 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|